Results 71 to 80 of about 953 (169)

Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study. [PDF]

Int J Chron Obstruct Pulmon Dis
Cherian M, Dell'Aniello S, Suissa S.
europepmc   +1 more source

Neuroprotective Activity of 3-((6-(Phenylethynyl)pyridin-3-yl)oxy)quinuclidine: A Potential Ligand for the Treatment of Alzheimer's Disease. [PDF]

ACS Chem Neurosci
Cavagnero PS, Sánchez Y, Fell B, Ramírez Molina O, Gavilán J, Polo EA, Fuentealba J, Gutierrez M, Jiménez CA, López JJ.   +9 more
europepmc   +1 more source

Temporal and Partial Reversal of Airflow Limitation in Patients With COPD Treated With Single-Inhaler Long-Acting Dual Bronchodilators. [PDF]

Clin Respir J
Lu Y, Zhou Y, Xue L, Tian H, Han J, Yang Y, Guo Y, Jiang W, Chen C, Wang L, Song Y.   +10 more
europepmc   +1 more source

ChemInform Abstract: Synthesis and Pharmacological Properties of 2‐ and 2,3‐Substituted Quinuclidines.

, 1988
T. K. TRUBITSYNA, E. E. MIKHLINA, A. D. YANINA, L. N. YAKHONTOV   +3 more
core   +1 more source

Elexacaftor/Tezacaftor/Ivacaftor Supports Treatment for CF with ΔI1023-V1024-CFTR. [PDF]

Int J Mol Sci
Huang Y, Gonzales Cordova JM, Penrod S, Bendy LL, Cheng PC, Sanders DB, Davis MD, Gaston B, Chmiel JF.   +8 more
europepmc   +1 more source

Economic evaluation of single-inhaler triple therapy for chronic obstructive pulmonary disease in Thailand. [PDF]

BMJ Open Respir Res
Dilokthornsakul P, Dilokthornsakul P, Chongmelaxme B, Niyompattama A.   +3 more
europepmc   +1 more source

Synthesis of New Bridged Tetrahydro-b-Carbolines and Spiro-Fused Quinuclidines.

, 2001
Wanner, M.J., Gremmen, C., Koomen, G.J., Burm, B.E.A.   +3 more
core   +1 more source

Capromorelin promotes weight gain in cats with unintended weight loss: a randomized, masked, placebo-controlled clinical trial. [PDF]

J Feline Med Surg
Wofford JA, Milliken MacKinnon A, Heinen E.   +2 more
europepmc   +1 more source

A phase 2 pharmacokinetic and pharmacodynamic dose-finding study of oral NEPA for chemotherapy-induced nausea and vomiting in pediatric patients with cancer. [PDF]

Support Care Cancer
Patel P, Arakaev O, Melnikov M, Dementieva N, Bernareggi A, Chen T, Spinelli T, Chaleff S.   +7 more
europepmc   +1 more source